| Acute monocytic leukemia | |
|---|---|
 | |
| Acute monocytic leukemia with its cytochemical profile | |
| Specialty | Hematology, oncology |
| Prognosis | Five-year survival rate: 23.7%[1] |
Acute monocytic leukemia (AMoL, or AML-M5)[2] is a type of acute myeloid leukemia. In AML-M5 >80% of the leukemic cells are of monocytic lineage.[3] This cancer is characterized by a dominance of monocytes in the bone marrow. There is an overproduction of monocytes that the body does not need in the periphery. These overproduced monocytes interfere with normal immune cell production which causes many health complications for the affected individual.
- ^ "Leukemia Survival Rates". Roswell Park Comprehensive Cancer Center. Retrieved March 9, 2023.
- ^ "Acute Myeloid Leukemia – Signs and Symptoms".
- ^ "Acute Monocytic Leukemia – an overview | ScienceDirect Topics". www.sciencedirect.com. Retrieved 2021-03-06.